Objectives: A significant number of patients suffering ruptured abdominal aortic aneurysms (RAAA) present to facilities lacking means of definitive management. Given the mortality and morbidity of untreated RAAA, these patients require resuscitation and transfer to tertiary referral centers for definitive surgery and postoperative care. As a tertiary referral center, we sought to evaluate the outcomes of patients being transferred by either ground ambulance or Flight-For-Life (FFL) vs those patients who present directly to the treating hospital.
Methods: A retrospective review was performed of patients presenting to, or transferred to, a tertiary referral hospital between 1998 and 2015. Main outcomes were survival, ventilation days, intensive care unit days, and length of stay. Comparisons were made using the c 2 test, t-test, and Wilcox rank sum test. Survival estimates were calculated using the Kaplan-Meier method and compared using the log-rank test.
Results: There were 160 patients identified in whom open or endovascular repair of a RAAA was attempted: 44% (n ¼ 71) presented directly to the emergency department, 26% were transferred by ground (n ¼ 41), and 30% (n ¼ 48) were transferred by FFL. Patients presenting directly to the tertiary center had a lower admitting systolic blood pressure (P < .001), decreased time to operation (P < .001), and lower 24-hour mortality (P ¼ .012). Mean distance traveled was 34.48 6 35.96 for ground transport and 49.37 6 37.02 miles for FFL. Time to operation was longer in the ground transport when compared to FFL (251.35 6 269.22 vs 161.29 6 158.81 minutes). There was no difference in 30-day (P ¼ .070), 6-month (P ¼ .192), or 12-month (P ¼ .305) survival between the three groups.
Conclusions: Patients transferred by ground or by FFL to a tertiary referral center for repair of RAAA do not experience increased mortality compared to patients presenting directly to the tertiary center. Prompt recognition and transfer of patients by the referring center, and wellorganized advanced life support transport services, are critical components of this process. Regionalization of care appears to be a feasible strategy for the management of ruptured aortic aneurysms. Objectives: Differences in pathophysiology, anatomy, operative approach, indication for repair, and outcomes of abdominal aortic aneurysms (AAAs) have been described for women vs men. Women with AAA exhibit more rapid aneurysm growth and greater rupture risk at equivalent diameters. Evidence suggests that biomechanical peak wall stress (PWS) derived from finite-element analysis (FEA) of AAAs is a superior predictor of clinical outcomes compared to maximum transverse diameter (MTD). The goal of this study was to investigate differences in the calculated PWS of AAAs between men and women.
Methods: A total of 35 men and 35 women with infrarenal AAAs with 45-55 mm MTD undergoing computed tomography angiography were identified. Customized image processing algorithms extracted patientspecific AAA geometries from raw Digital Imaging and Communications in Medicine images. The resulting aortic reconstructions incorporated patient-specific and regionally resolved aortic wall thickness, intraluminal thrombus, and wall calcifications. Aortic computational models were loaded with 120 mm Hg blood pressure using commercially available finite-element analysis solvers.
Results: No significant differences were found between men and women's maximum transaortic diameters (50.5 6 3.1 vs 49.8 6 2.9 mm; P ¼ .34). PWS was found to be significantly higher in women (299 6 51 vs 257 6 53 kPA; P ¼ .001, Fig) . This difference persisted when PWS was normalized by diameter (6.0 6 1.1 vs 5.2 6 1.1 kPa/mm; P ¼ .001). Neither mean aortic wall thickness (2.38 6 0.52 vs 2.34 6 0.50 mm; P ¼ .69) nor wall thickness at location of PWS (2.36 6 0.60 vs 2.20 6 0.46 mm; P ¼ .20) varied by sex. While there were no sex-associated differences in aneurysm volume (86.6 6 27.0 vs 94.8 6 25.5 cm 3 ; P ¼ .76) or intraluminal thrombus volume (14.2 6 11.7 vs 16.3 6 13.4 cm 3 ; P ¼ .33), women's AAAs had significantly increased maximum Gaussian curvature (0.032 6 0.011 vs 0.025 6 0.015 mm -2 ; P ¼ .03). Conclusions: Comparably sized AAAs in women have significantly higher PWS. No significant differences were found in wall thickness, aneurysm volume, or thrombus volume, suggesting that morphological differences account for most of the disparity in PWS. Maximum Gaussian curvature, a measure of aneurysm morphology, was significantly different between the two groups. These results suggest that men and women possess distinct aneurysm geometries and that PWS-derived rupture risk prediction may be a more reliable estimator of rupture risk than MTD in all patients. Objectives: Recent studies have shown that patients with uncomplicated acute type B aortic dissection (uATBAD) who have enlarged descending thoracic aortic diameters are at high risk of developing complications. This study aimed to determine the effect of maximum ascending aortic diameter and area on outcomes in patients with uATBAD.
Methods: All patients admitted with uATBAD from June 2000 to January 2015 were reviewed, and those with available imaging were included. All measurements were obtained by a specialized cardiovascular radiologist. The maximum ascending aortic diameter and area were measured. Outcomes, including the need for intervention and mortality, were tracked over time. Data were analyzed by stratified Kaplan-Meier and multiple Cox regression analysis using SAS 9.4 software.
Results: During the study period, 304 patients with uATBAD were admitted, with 245 having noncontrast computed tomography and 131 having computed tomography angiography imaging and adequate follow-up available for analysis. The cohort had an average age of 60.9 years (60% male, 53% Caucasian). Ascending aortic area >12.1 cm 2 was highly associated with subsequent arch/proximal progression (P < .0006). Ascending diameter >40.8 mm predicted lower interventionfree survival (P ¼ .01). Ascending aortic area >12.1 cm 2 predicted lower intervention-free survival (P ¼ .005). Maximum aortic diameter along the length of the aorta >44 mm persisted as a risk factor for mortality (hazard ratio [HR], 7.34; P ¼ .0008) after adjustment for diabetes mellitus (6.4; P ¼ .0008), age (1.06/year; P ¼ .0006), history of stroke (HR, 5.03; P ¼ .0081), syncope on admission (21.11; P ¼ .007), and ascending diameter >40.8 mm (1.09; P ¼ .85). Max ascending aortic diameter failed to predict overall survival when two groups were compared >40.8 and < 40.8 (P ¼ .12). However maximum aortic diameter along the length of the aorta >44 mm held true as previously demonstrated (P ¼ .0009). Maximum aortic diameter along the length of the aorta >44 mm persisted as a risk factor for decreased intervention-free survival (hazard ratio, 3.142; P ¼ .0038), syncope on admission (26.3; P ¼ .004), pleural effusion on admission (3.02; P ¼ .0008), and ascending diameter >40.8 mm (2.01; P ¼ .04).
Conclusions: uATBAD patients with ascending aortic area >12.1 cm 2 are at high risk of developing subsequent arch/proximal progression and may require closer follow-up or earlier intervention. Ascending aortic size (diameter and area) is predictive of decreased intervention free survival in patients with uATBAD.
Methods: Between March 2001 and Sept 2016, 53 patients (38 men; mean age, 55 6 13) with an acTBD were treated with TEVAR for malperfusion (55%), aortic rupture (15%), or persistent untreatable pain (30%) as a sign of pending rupture. Four patients (8%) had undergone previous aortic surgery.
Results: Technical success (coverage of the primary tear site) was achieved in 48 patients (91%). Overall hospital mortality rate was 9% (n ¼ 5). Causes of death were rupture during the procedure or on the first postinterventional day in two patients and redissection (ascending aorta n ¼ 2, descending aorta n ¼ 1) with consequent aortic rupture after TEVAR in the remaining three. Permanent neurologic dysfunction occurred in 3 patients (stroke n ¼ 1, paraplegia n ¼ 2). Nineteen patients (36%) developed early endoleaks (type Ia, n ¼ 5; type Ib, n ¼ 11; type II, n ¼ 2; type Ib plus II, n ¼ 1) and were observed throughout the postinterventional period. These seven patients (37%) needed secondary endovascular intervention (n ¼ 3) or conventional surgery (n ¼ 4) due to aortic progression (mean interval after procedure 92 6 56 months). Secondary endoleaks were observed in nine patients with consequent reintervention in three patients. The actuarial survival was 88%, 76%, and 58% at 1, 5, and 10 years, respectively. Freedom from treatment failure at 1, 5, and 10 years (including reintervention, aortic rupture, device-related complications, aortic-related death, or sudden, unexplained late death) was 76 %, 74%, and 74%, respectively.
Conclusions: TEVAR in the treatment of acute complicated type B aortic dissection proves to be an excellent treatment modality in this high risk patient cohort. Refinements, especially in stent design and application, may further reduce the rate of endoleaks and improve the prognosis of patients in this life-threatening situation.
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